Dong Sung Pharmaceutical’s Chairman Lee Yang-gu has filed for a provisional injunction to suspend the duties of CEO Na Won-kyun and two directors. The injunction aims to prevent CEO Na from performing his duties until a final judgment is made. This follows a previous lawsuit by Chairman Lee to prevent the listing of new shares, which was withdrawn voluntarily, and is seen as an attempt to block CEO Na’s issuance of new shares through third-party allocation.
Original Article: Read More
Auto-posted at: 2025-05-13 21:02:21